Grand Rapids, MI, August 2023—Grand Rapids Ear, Nose & Throat, a Parallel ENT & Allergy supported practice, proudly announces the recognition of six practice physicians as “Top Doctors” in the ear, nose and throat category by Grand Rapids Magazine for 2023. Top Doctors recognition is a peer-nominated distinction.
Continue reading
ENT & Allergy of Delaware, a Parallel ENT & Allergy supported practice, proudly announces the recognition of four practice physicians as “Top Doctors” by Philadelphia Magazine for 2023. Top Doctors recognition is a peer-nominated distinction.
Continue reading
San Antonio, May 15, 2023—The Ear Institute of Texas, which is a Parallel ENT & Allergy supported practice, proudly announces their 20th anniversary of providing exceptional medical and surgical care for ear, nose, and throat disorders, including care for dizziness and audiology services. The team at the Ear Institute of Texas is celebrating the anniversary throughout the month of May, which is also National Better Hearing and Speech Month.
The Ear Institute of Texas was founded in 2003 by Dr. Lance Jackson. His mission was to bring the best otologic and neurotologic care to the San Antonio region.
Dr. Jackson and his team are also focused on advancing the practice of otology and neurotology care for the future.
“We have striven to be on the forefront of otology care. This involves offering a broad range of treatment for hearing loss, including not only conventional hearing aids but also bone anchored hearing aids, cochlear implantation, and the new Earlens device. Over time, we added additional physicians and other types of care provided through the practice, so we could provide comprehensive otolaryngology care. This included expanding for the most advanced care for voice and swallow issues, as well as all other aspects of ENT. We have done this by adding additional physicians of highest quality,” he said.
Recently the Ear Institute of Texas and the Hearing Institute of Texas joined Parallel ENT & Allergy as supported practices. Parallel provides EIT and HIT non-clinical, practice management services to support high-quality patient care.
“The 20th anniversary of the Ear Institute of Texas demonstrates Dr. Jackson’s leadership and commitment to the San Antonio and broader Texas market,” said Glenn Noble, CEO of Parallel ENT & Allergy. “We are thrilled to be a part of celebrating this milestone with them and building a strong future for the practice in the years ahead.”
The Ear Institute of Texas and Hearing Institute of Texas has five board-certified physicians and total staff of 50. EIT provides medical and surgical treatments of the ear, nose, throat, and other ENT disorders for patients of all ages. This includes all forms of otolaryngology conditions, including subspecialty care of both otology/neurotology and laryngology conditions by fellowship-trained physicians. The practice also offers vestibular testing, allergy evaluation and treatments including immunotherapy options, and laryngoscopy. The Hearing Institute of Texas fits patients with hearing aids and provides all aspects of audiology care, including cochlear implantation. Learn more at https://eioftx.com.
Parallel ENT & Allergy is a physician-centric practice management organization for ENT and allergy practices. Parallel provides strategic, operational, and administrative support, so physicians can spend less time worrying about the business of medicine and more time caring for their patients. To learn more about Parallel ENT & Allergy, or to inquire about becoming a supported practice, visit https://parallelenta.com.
Parallel will provide EIT and HIT non-clinical, practice management services to support high-quality patient care.
Founded in 2003 by Dr. Lance Jackson, the Ear Institute of Texas and Hearing Institute of Texas has five board-certified physicians and total staff of 50. EIT provides medical and surgical treatments of the ear, nose, throat, and other ENT disorders for patients of all ages. This includes all forms of otolaryngology conditions, including subspecialty care of both otology/neurotology and laryngology conditions by fellowship-trained physicians. The practice also offers vestibular testing, allergy evaluation and treatments including immunotherapy options, and laryngoscopy. The Hearing Institute of Texas fits patients with hearing aids and provides all aspects of audiology care, including cochlear implantation.
“We are happy to welcome the physicians and staff from the Ear Institute of Texas and the Hearing Institute of Texas to the growing Parallel team,” says Glenn Noble, Parallel’s CEO. “The practice has a reputation for excellence in the greater San Antonio area and South Texas region. We are confident that together we can continue to grow and provide the best care for patients.”
EIT chose Parallel ENT & Allergy after a comprehensive search for a practice management partner led by Bayshore Growth Partners.
“We are thrilled to join Parallel ENT & Allergy. After evaluating the options in practice management, we found that Parallel has a great team with a philosophy that will allow us to maintain clinical autonomy. With Parallel’s shared services, such as revenue cycle management, IT, recruiting and other critical business services, we are poised to take our practice to the next level. We are excited to lead and expand ear, nose, throat and allergy care in the San Antonio and broader Texas market,” said Lance Jackson, MD and founder of The Ear Institute and Hearing Institute of Texas.
Parallel ENT & Allergy is backed by Trinity Hunt Partners, a growth-oriented private equity firm with deep healthcare experience.
Parallel ENT & Allergy is a physician-centric practice management organization for ENT and allergy practices. Parallel provides strategic, operational, and administrative support, so physicians can spend less time worrying about the business of medicine and more time caring for their patients. To learn more about Parallel ENT & Allergy, or to inquire about becoming a supported practice, visit https//parallelenta.com.
Trinity Hunt Partners is a growth-oriented middle market private equity firm with over $1.7 billion of assets under management focused on partnering with business owners to build world-class business, healthcare, and consumer services companies. Trinity Hunt has earned a reputation for providing strategic, operational, and financial expertise to take entrepreneurial services companies to the next level.
The firm has been consistently named a Top 50 Founder-Friendly Private Equity Firm by Inc. Magazine. Additionally,Trinity Hunt is listed at No. 2 on the 2022 Top North American Small-Cap Buyout Firms List compiled by HEC Paris and Dow Jones. Trinity Hunt currently ranks at No. 4 among PE firms on the HEC-Dow Jones Best Performing Small-Cap Private Equity Firms ranking. For more information, please visit www.trinityhunt.com.
###
NEWARK, DE, April 6, 2023—ENT & Allergy of Delaware, a Parallel ENT & Allergy supported practice, has added a fourth location with the recent acquisition of Wilmington Otolaryngology. The acquisition strengthens ENT & Allergy of Delaware’s position as a quality, innovative ENT and allergy leader in the mid-Atlantic region.
Founded in 2010, ENT & Allergy of Delaware has a preeminent team of 17 board-certified physicians, 12 audiologists, and over 140 support staff. The practice offers comprehensive ear, nose and throat care. The practice also offers allergy testing and treatment, audiology, and hearing aid services.
Wilmington Otolaryngology has been serving patients in Wilmington for several decades. Board-certified physicians Lauren Bogdan, MD and Jay Luft, MD lead the practice.
“We are thrilled to add Wilmington Otolaryngology to our practice group. Lauren Bogdan, MD and Jay Luft, MD, are well known and respected in the community. Together, we are proud to deliver the most comprehensive ENT and allergy services in the region,” said Will Sheppard, MD of ENT & Allergy of Delaware.
“Joining ENT & Allergy of Delaware is an opportunity to be a part of a premier practice in the mid-Atlantic. We have been colleagues for a long time in the area, and our philosophies align well,” said Lauren Bogdan, MD from Wilmington Otolaryngology.
“ENT & Allergy of Delaware is our flagship practice in the Mid-Atlantic region. We welcome the opportunity to support the providers from Wilmington Otolaryngology and look forward to seeing their practice grow on the ENT & Allergy of Delaware platform,” said Glenn Noble, CEO for Parallel ENT & Allergy.
Parallel ENT & Allergy removes the non-clinical burdens of practice management by providing administrative support through shared services. The shared services include recruiting, human resources, IT services, finance and accounting and marketing. Parallel ENT & Allergy is backed by Trinity Hunt Partners, a growth-oriented private equity firm with deep healthcare experience.
ABOUT PARALLEL ENT & ALLERGY
Parallel ENT & Allergy is a physician-centric practice management organization for ENT and allergy practices. Parallel provides strategic, operational, and administrative support, so physicians can spend less time worrying about the business of medicine and more time caring for their patients. To learn more about Parallel ENT & Allergy, or to inquire about becoming a supported practice, visit https//parallelenta.com.
ABOUT TRINITY HUNT PARTNERS
Trinity Hunt Partners is a growth-oriented middle market private equity firm with over $1.2 billion of assets under management focused on partnering with business owners to build world-class business, healthcare, and consumer services companies. Trinity Hunt has earned a reputation for providing the strategic, operational, and financial expertise to take entrepreneurial services companies to the next level. The firm has been consistently named a Top 50 Founder-Friendly Private Equity Firm by Inc. Magazine. In 2022, Trinity Hunt ranked No. 13 among 517 PE firms on the inaugural HEC-Dow Jones Best Performing Small-Cap Private Equity Firms ranking. For more information, please visit www.trinityhunt.com.
NEWARK, Del., Oct. 6, 2022 /PRNewswire/ — Parallel ENT & Allergy Partners has added a second state to its roster of high-quality, innovative ENT and allergy partners with the addition of Grand Rapids ENT.
“We are elated for the talented group of physicians and staff at Grand Rapids ENT to partner with the Parallel team,” says Glenn Noble, Parallel’s CEO. “The practice has a strong presence and reputation both locally and across the state of Michigan. We are very much looking forward to working with Dr. Pfennig and the Grand Rapids ENT team as we continue to rapidly grow and expand Parallel’s footprint.”
For more than 25 years, Grand Rapids ENT has provided a full range of ear, nose, and throat services to the Greater Grand Rapids area. Staffing six experienced, board-certified physicians, the practice also offers allergy testing and treatment, audiological testing, hearing aid sales and services, and reconstructive and cosmetic facial plastic surgery.
“Backed by Parallel ENT & Allergy Partners, we can now focus on providing even greater care for our patients,” said Thomas Pfennig, DO, a board-certified ear, nose throat and allergy specialist with Grand Rapids ENT. “This is a win for us and our patients. Our philosophies aligned perfectly with Parallel, and we’re excited to build an even stronger practice together in the years ahead.”
Grand Rapids ENT Physician providers include Gregory J. Artz, M.D., Neurotologist, Claudell Cox, M.D., Otolaryngologist, Robert J. Meleca, M.D., Otolaryngologist, Thomas W. Pfennig, D.O., Otolaryngologist, Joe Taylor, M.D. Pediatric Otolaryngologist, and Devin Mistry, D.O. Otolaryngologist and Rhinologist.
The parallel is backed by Trinity Hunt Partners, a leading private equity firm with deep experience in healthcare services.
ABOUT PARALLEL
Parallel ENT & Allergy Partners is a physician-centric management organization specifically designed to address the unique needs and demands of ENT and allergy practices. Working in parallel with its partner practices, the organization provides strategic, operational, and administrative support, so physicians can spend less time worrying about the business of medicine and more time caring for their patients. Parallel ENT & Allergy Partners currently incorporates the expertise of 21 doctors at eight locations in two states (Delaware and Michigan).
To learn more about Parallel ENT & Allergy Partners, please visit https://parallelenta.com.
To inquire about opportunities to partner with us, email Glenn Noble, Chief Executive Officer (GNoble@parallelenta.com), or Justin Kuperberg, Chief Development Officer (Jkuperberg@jkuperberg@parallelenta.com).
ABOUT TRINITY HUNT PARTNERS
Trinity Hunt Partners is a growth-oriented middle market private equity firm with over $1.2 billion of assets under management focused on partnering with business owners to build world-class business, healthcare, and consumer services companies. Trinity Hunt has earned a reputation for providing the strategic, operational, and financial expertise to take entrepreneurial services companies to the next level. The firm has been consistently named a Top 50 Founder-Friendly Private Equity Firm by Inc. Magazine. In 2022, Trinity Hunt ranked No. 13 among 517 PE firms on the inaugural HEC-Dow Jones Best Performing Small-Cap Private Equity Firms ranking.
For more information, please visit www.trinityhunt.com.
PRESS CONTANCT:
Avery Meginnis
Slant Partners
am@slantpartners.com
704.942.1598
SOURCE: Parallel ENT & Allergy Partners
Parallel and its partners share a commitment to the highest quality patient care, sustainable growth, and a culture of respect.
In March of 2022, Parallel completed a strategic partnership with ENT & Allergy of Delaware (“ENTAD”). Founded in 2010, ENTAD is a leading ENT and allergy services provider with a preeminent team of 15 physicians, 12 audiologists, and over 140 support staff. ENTAD will continue to operate under its brand. “At ENTAD, we are proud of our reputation for the highest quality clinical care and culture of collaboration, trust, and respect,” said Dr. Kieran Connolly, MD, a founder of ENTAD. “In Parallel and Trinity Hunt, we have found like-minded partners with the right experience and track record to accelerate ENTAD’s growth while preserving our clinical independence and core values.”
Parallel will provide scalable support services to ENTAD and future partner practices to promote long-term growth and allow providers to focus on delivering the highest quality patient care. Glenn Noble, a seasoned healthcare services executive with extensive operational and strategic experience, has joined Parallel as CEO. “I am excited to be working in tandem with ENTAD and Trinity Hunt to develop Parallel into a culture-focused, best-in-class leader in the ENT & Allergy space. Parallel has a clear strategic vision dedicated to simplifying the complex healthcare environment and improving the experiences of our ENT & Allergy practice partners, patients and employees,” said Glenn Noble.
Backing Parallel is Trinity Hunt Partners, a leading private equity firm with deep experience in healthcare services. “We look forward to supporting Parallel in its growth initiatives, including additional affiliations with like-minded practices, as it scales to become a market-leading player in the ENT & Allergy space,” said John Oakes, Principal at Trinity Hunt.
Baird served as exclusive financial advisor and Stevens & Lee served as legal advisor to ENTAD. McGuireWoods LLP served as legal advisor to Trinity Hunt. Terms were not disclosed.
Parallel ENT & Allergy is a physician-centric management support organization for ENT and Allergy practices. Parallel shares a commitment to the highest quality patient care, sustainable growth, and a culture of respect. Working in parallel with its partner practices, the management services organization provides scalable support services to promote long-term growth while preserving clinical autonomy for its physicians.
Parallel brings together the best people, processes, and technology—and the highest standards of care—to pave the way for the long-term success of practices, physicians, and patients.
For more information, please visit www.parallelenta.com.
Trinity Hunt Partners is a growth-oriented middle market private equity firm with over $1.2 billion of assets under management focused on partnering with business owners to build world-class business, healthcare, and consumer services companies. Trinity Hunt has earned a reputation for providing the strategic, operational, and financial expertise to take entrepreneurial services companies to the next level. The firm has been consistently named a Top 50 Founder-Friendly Private Equity Firm by Inc. Magazine. In 2022, Trinity Hunt ranked No. 13 among 517 PE firms on the inaugural HEC-Dow Jones Best Performing Small-Cap Private Equity Firms ranking.
For more information, please visit www.trinityhunt.com.